Venom-derived ion channel inhibitors have strong channel selectivity, potency, and stability; however, tracking delivery to their target can be challenging. Herein, we utilized luminescent quantum dots (QDs) conjugated to margatoxin (MgTx) as a traceable vehicle to target a voltage-dependent potassium channel, Kv1.3, which has a select distribution and wellcharacterized role in immunity, glucose metabolism, and sensory ability. We screened both unconjugated (MgTx) and conjugated MgTx (QD-MgTx) for their ability to inhibit Shaker channels Kv1.1 to Kv1.7 using patch-clamp electrophysiology in HEK293 cells. Our data indicate that MgTx inhibits 79% of the outward current in Kv1.3-transfected cells and that the QDMgTx conjugate is able to achieve a similar level of block, albeit a slightly reduced efficacy (66%) and at a slower time course (50% block by 10.9 AE 1.1 min, MgTx; vs.
resulting from CNS neuronal disorders, chronic renal failure, cardiac arrhythmia, diabetes, asthma, inflammation, and autoimmune diseases (Kazama 2015; Rubaiy 2016; Skibsbye and Ravens 2016; Yang and Nerbonne 2016) . Having the ability to concentrate and track ion channel inhibitors, therefore, provides an advantage for targeted delivery of such molecules to well-characterized, voltage-gated ion channels and the concomitant regulation of excitability to mitigate disease. Herein, we utilized luminescent quantum dots (QDs) conjugated to a pore-blocking peptide as a traceable vehicle to target a delayer rectifier, voltagedependent potassium channel, Kv1.3, which has a select distribution (Kues and Wunder 1992) , and well-characterized role in immunity, glucose metabolism, and sensory ability Lam and Wulff 2011; Upadhyay et al. 2013; Chhabra et al. 2014; Koshy et al. 2014; Xie et al. 2015) .
Kv1.3 is a mammalian homolog of the Shaker subfamily that classically serves to stabilize the resting potential and time the inter-spike interval in excitable neurons (Yellen 2002; Jan and Jan 2012) . Kv1.3 has a select distribution within the CNS where it is expressed in the mitral cells of the olfactory bulb (OB), the principal cells of the pyriform cortex, and within the dentate gyrus of the hippocampus (Kues and Wunder 1992; Fadool and Levitan 1998; Fadool et al. 2000; Trimmer 2015) . Kv1.3 is also an important signaling step in a variety of autoimmune diseases through triggering T-lymphocyte activation in multiple sclerosis, arthritis, and chronic respiratory problems (Rangaraju et al. 2009; Beeton et al. 2011; Lam and Wulff 2011; Chi et al. 2012; Toldi et al. 2013; Koshy et al. 2014) . Mice with a gene-targeted deletion of Kv1.3 (Kv1.3 À/À ) have an unusual phenotype that encompasses both metabolism and sensory processes (Xu et al. 2003; Fadool et al. 2004) . The mice have an enhanced olfactory ability in terms of both odor discrimination and threshold (referred to as Super-smeller mice), and have increased expression of G-protein-coupled odorant receptors and G olf Biju et al. 2008) . They also have increased firing frequency of mitral cells in the olfactory bulb stemming from a slightly shifted membrane potential (Fadool et al. 2011) . Cumulatively, the Kv1.3 À/À mice are thinner than their wild-type counterparts without caloric restriction, are resistant to diet-and geneticinduced obesity, and have an increased total energy expenditure in the dark cycle (Xu et al. 2003 (Xu et al. , 2004 Fadool et al. 2004; Tucker et al. 2008 Tucker et al. , 2012a Thiebaud et al. 2014 ).
Owing to the ability for Kv1.3 channel to serve as a metabolic target to balance body weight and simultaneously enhance olfactory ability, we took advantage of known peptide blockers of this channel to investigate the feasibility of targeting QD-conjugates to Kv1.3 in human embryonic kidney 293 (HEK293) cells and mouse OB slices. Owing to their selectivity, potency, and stability, venomderived ion channel inhibitors make amenable drug candidates (Pineda et al. 2014; Kalia et al. 2015; Undheim et al. 2015) . We focused our efforts upon the venomderived peptide, margatoxin (MgTx), because of its noted robust thermal stability (Garcia-Calvo et al. 1993) and the ease for which we predicted it could be conjugated to QDs. MgTx is a 39 amino acid peptide derived from the venom of Centruroides margaritatus with an IC 50 of 11.7 pM against Kv1.3 (Garcia-Calvo et al. 1993; Knaus et al. 1995; Bartok et al. 2014) . We and others have demonstrated the ability of MgTx to block Kv1.3 using a variety of heterologous systems and native cells (Garcia-Calvo et al. 1993; Spencer et al. 1997; Fadool and Levitan 1998; Ghanshani et al. 2000; Colley et al. 2004; Menteyne et al. 2009; Fadool et al. 2011; Mast and Fadool 2012a; Jang et al. 2015) . A variety of other venom-derived ion channel inhibitors are being used in clinical trials for autoimmune diseases and the treatment of pain, for example (Hagen et al. 2007 (Hagen et al. , 2008 (Hagen et al. , 2011 Beeton et al. 2011; Chi et al. 2012; Yang et al. 2013) . Like MgTx, these molecules have high selectivity by targeting the vestibule of the channel, however, targeting to a specific location can be problematic.
There are a variety of different types of nanoparticles that can aid in delivery toward a target of interest, including luminescent quantum dots (QDs). Luminescent QDs made of CdSe-ZnS core-shell nanocrystals have unique optical and spectroscopic properties (Mattoussi et al. 2012) . Others have designed peptide inhibitors with fluorescent tags, however, binding peptides to QDs affords the ability to concentrate the peptide on the QD surface as well as provides the advantage to conjugate multiple, different peptides to a single QD (Susumu et al. 2009 ). Molecules that increase penetration through cell or epithelial membranes can also be co-bound to the nanoparticle along with the drug or inhibitor of interest (Guo et al. 2016; Sheng et al. 2016) . Dihydrolipoic acid is a ligand with strong affinity for ZnS overcoated QDs. When dihydrolipoic acid is appended with polyethylene glycol (PEG), either inert or chemically reactive (including carboxy, amine, or azide), it yields QDs that are stable over a broad range of pH and are biocompatible (Palui et al. 2012a,b) . MgTx has many free amine groups, thus we utilized its structural chemistry to our advantage.
We developed a protocol using carbodiimide coupling chemistry (EDC/NHS) for effective conjugation of the peptide MgTx to QDs, such that this conjugate could be used to label cells expressing Kv1.3. To better understand the selectivity of the new conjugate, we screened both unconjugated (MgTx) and quantum dot-conjugated margatoxin (QD-MgTx) for their ability to block Shaker family members Kv1.1 to Kv1.7. We honed our electrophysiological analysis to Kv1.3 in native OB slices where we explored predicted changes in excitability induced by block of Kv1.3 conductance for neurons that are well characterized to carry a large proportion of the outward current via Kv1.3 (Fadool and Levitan 1998; Colley et al. 2004; Fadool et al. 2004 ). Our data demonstrate a retention of known biophysical properties associated with block of the vestibule of Kv1.3 by MgTx compared to that of the conjugated nanoparticle (QD-MgTx), as well as retention of QD properties following conjugation. These data infer that nanoparticle conjugates are potential tools to deliver ion channel inhibitors to targeted tissues in vivo.
Materials and methods

Ethical approval
All animal experiments were approved by the Florida State University (FSU) Institutional Animal Care and Use Committee under protocol #1427 and were conducted in accordance with the American Veterinary Medicine Association and the National Institutes of Health. For preparation of OB slices, mice were anesthetized with isoflurane (Aerrane, Baxter, Deerfield, IL, USA) using the Institutional Animal Care and Use Committee-approved drop method and were then killed by decapitation (American Veterinary Medicine Association Guidelines on Euthanasia, June 2007).
Animal care
All mice (C57BL/6J background strain; The Jackson Laboratory, Bar Harbor, ME, USA) were singly housed in conventional style open cages at the FSU vivarium on a standard 12 h/12 h light/dark cycle and were allowed ad libitum access to 5001 Purina Chow (Purina, Richmond, VA, USA) and water. Mice of both sexes at postnatal days 15-30 (body weight ranged from 5.6 to 14.2 g) were used for slice electrophysiology experiments.
Solutions and reagents
Phosphate-buffered salines (PBS) for conjugation (pH 6.5, 7.9) and immunocytochemistry (pH 7.4) were prepared as previously described (Clyner 2007; Biju et al. 2008) . The bath and pipette solutions for the electrophysiology experiments using HEK293 cells were prepared as previously reported (Cook and Fadool 2002) . The artificial cerebrospinal fluid (ACSF), sucrose-modified ACSF, and intracellular pipette solution for slice electrophysiology experiments were carefully monitored for osmolarity and prepared as previously reported (Fadool et al. 2011; Tucker et al. 2013; Thiebaud et al. 2016) . All salts and sugars were purchased from Sigma-Aldrich (St Louis, MO, USA) or Fisher Scientific (Pittsburgh, PA, USA). MgTx (#M8437; Sigma Aldrich) was reconstituted in PBS to 1 lM with 0.01% bovine serum albumin and stored as stocks at À20°C. On the day of the experiment, the stock solution was diluted in either HEK293 pipette solution or ACSF, for recording cell-attached macroscopic currents from HEK293 cells or action potential firing frequency in a current-clamp configuration from OB slices, respectively. Final working concentration of MgTx back-filled in the pipette was 1 nM.
Quantum dot (QD) growth, phase transfer, and conjugation The luminescent QDs used in this study were made of CdSe-ZnS core-shell nanocrystals, had an overall inorganic core-shell diameter of~6 nm, and emitted in the red region of the visible spectrum (peak at 633 nm) (Yu and Peng 2002; Clapp et al. 2006) . These nanocrystals were grown stepwise, starting with the core, followed by ZnS over-coating, using high-temperature reduction of cadmium, selenium, zinc, and sulfur precursors in coordinating solvent mixtures made of alkylphosphines, alkyphosphine-carboxyl, and alkylamines, following the protocols described in previous reports (Yu and Peng 2002; Clapp et al. 2006) . The native capping ligands, made of a mixture that included trioctylphosphine/trioctylphosphine oxide (TOP/TOPO) and alkyl carboxy, were exchanged with polyethylene glycol-appended lipoic acid (LA-PEG) to promote the dispersion of the QDs in buffer media. The phase transfer strategy relied on the photochemical ligation of LA-PEG (oxidized form) combined with competitive displacement of the native ligands. Importantly, the phase transfer allowed for the introduction of a controllable fraction of reactive groups on the QD surface via mixed ligand exchange (Susumu et al. 2007 ). This permitted covalent coupling of MgTx peptide onto the QDs. In particular, QDs photoligated with 10% LA-PEG-COOH were coupled to the amine groups available on the MgTx via a 1-ethyl-2-(-dimethylaminopropyl)-carbodiimide)/N-hydroxysuccinimide (EDC/NHS) condensation reaction (Hermanson 2013) . Additional details on the phase transfer, conjugation steps, and purification of the conjugate can be found in previous reports (Susumu et al. 2007; Palui et al. 2012a) . The final concentration of the QD or QD-MgTx dispersion was determined from the absorbance value at 350 nm, using an extinction coefficient of the QDs (e.g., 350 nm = 2.467 9 10 À6 per M/cm) (Leatherdale et al. 2002) . The number of MgTx per QD conjugate (i.e., valence~15) was estimated from the reaction conditions (reagent concentration) and assuming 75% efficiency of the EDC condensation reaction (Hermanson 2013) . The QD-MgTx conjugates were stored at 4°C until the day of use. Final working concentration of QD-MgTx, back-filled in the pipette for cell-attached recordings, was 10 nM.
cDNA constructs All Shaker channel coding regions were downstream from a cytomegalovirus promoter. rKv1.3 channel was subcloned into the multiple cloning region of pcDNA 3 (Invitrogen, Carlsbad, CA, USA) at the unique HindIII restriction site as previously described (Holmes et al. 1996) . The eGFP-rKv1.3 construct (GFP-Kv1.3) was generously donated by J€ urgen Kupper (Kupper 1998 ) and subcloned into pcDNA 3 by the FSU Molecular Core Facility taking advantage of the same HindIII sites as above (Spear et al. 2015) . rKv1.1 and rKv1.2 constructs were generously provided by Dr. James Trimmer (University of California Davis, Davis, CA, USA) and were independently subcloned into the pcDNA 3 vector between the BamHI and HindIII restriction sites of the multiple cloning region. rKv1.4 and rKv1.5 cDNA were both expressed in pcDNA 3 and were a generous gift from Todd Holmes (University of California Irvine, Irvine, CA, USA) (Nitabach et al. 2002) . hKv1.6 (pcDNA 3 ) and rKv1.7 (pEGFP-C3) constructs were donated by Dr. Heike Wulff (University of California Davis). pCDM8 was a kind gift from Dr. Brian Seed (Harvard University, Boston, MA, USA) (Jurman et al. 1994) . DNA-encoding human CD8 was amplified from pCDM8 and subcloned into the pcDNA 3 vector between the BamH1 and EcoR1 restriction sites (Mast et al. 2010) .
Maintenance, transfection, and electrophysiology of HEK293 cells HEK293 cells were grown in Modified Eagle's Medium (#12360-038; Life Technologies/Gibco, Grand Island, NY, USA) supplemented with 2% penicillin/streptomycin (#P0781) and 10% fetal bovine serum (#16000-044). Plating to low density and transfection procedures were carried out as previously described (Cook and Fadool 2002) . Briefly, when cells reached 70-80% confluency they were transiently cotransfected with 1 lg Shaker cDNA plus 0.2 lg pCDM8 for 4 h using lipofectamine (#18324-012; Life Technologies/Invitrogen) in serum-reduced media (#31985-070) (Mast and Fadool 2012) . Twenty-four to thirty-six hours post-transfection, cells were incubated with Dynabeadsâ CD8 microparticles (#11147D; Life Technologies/Gibco) for 2 min to visualize channel-transfected cells (Mast and Fadool 2012) . Hoffman modulation contrast optics were used to visualize cells at 409 magnification (Axiovert 135; Carl Zeiss, Thornwood, NY, USA). Patch electrodes were fabricated from Jencons (M15/10; Jencons Limited, Bedfordshire, UK) or Sutter glass (BF150-86-15; Sutter Instrument Co., Novato, CA, USA) using a vertical puller (Model PP-830; Narishige, Tokyo, Japan). Tips were fire polished with a microforge (Model MF-830; Narishige) to achieve pipette resistances between 9 and 14 MΩ. Macroscopic currents were recorded at 20-22°C as acquired from cell-attached membrane patches using an Axopatch 200B patch-clamp amplifier (Molecular Devices/Axon Instruments, Sunnyvale, CA, USA). All voltage signals were generated and data were acquired with the use of an Axon Digidata 1200 A/D converter in conjunction with pClamp v10.3 software (Molecular Devices/ Axon Instruments). Recordings were filtered at 2 kHz and digitized at 2-5 kHz. Typically, patches were held (V h ) at À90 mV and stepped to a depolarizing potential of +40 mV (V c ) using a pulse duration (P d ) of 1000 ms and an inter-pulse interval of 60 s. Pipettes were tip-filled with pipette solution and back-filled with MgTx, QDs, or the QD-MgTx conjugate to allow within-patch comparison of the effect of the inhibitor, nanoparticle, or conjugate, respectively. Electrophysiological records were analyzed using Origin v8.0 (Microcal; Borland International, Scotts Valley, CA, USA), Excel v2013 (Microsoft Office, Redmond, WA, USA), and Prism 6 (Graph Pad, La Jolla, CA, USA). Patches were allowed to stabilize for 3-5 sweeps following patch formation and to release Kv channels from an inactivated state. Following stabilization (taken as Time 0), peak current amplitude was measured (I i , initial current) and then normalized as I i /I n (I n , current at time n) to compare change in peak current amplitude over time across experiments. In experiments for which step depolarization over time and channel conductance measurements were acquired for the same cell, patches were first stimulated with a control conductance protocol (V c = À90 mV, P d = 50 ms, stepped to final V c = +10 mV, in 5 mV increments) upon seal stabilization, then monitored for peak current amplitude over time (I i /I n ) for 25 min (min), and then restimulated with the conductance protocol. In this manner, using the control tip-filled solution, and back-filled pore inhibitor, nanoparticle, or conjugate, paired within-cell measurements could be achieved for both peak current amplitude (including kinetics) as well as channel conductance. Fitting parameters for inactivation and deactivation kinetics were as previously described (Cook and Fadool 2002) .
Olfactory bulb slice electrophysiology Mice (postnatal 21-35 days C57BL/6J) were anesthetized between 10:00 am and 12:00 pm by inhalation of isoflurane (see Ethics section), quickly decapitated, and then the OBs were exposed by removing the dorsal and lateral portions of the skull between the lambda suture and the cribriform plate. The OBs were harvested and 300 lm coronal sections of the OBs were prepared using oxygenated sucrose-modified ACSF solutions during vibratome sectioning (Vibratome/Leica Model 1000, Wetzlar, Germany), as previously described (Fadool et al. 2011; Thiebaud et al. 2016) . Slices were maintained at 20-22°C in an interface chamber (Krimer and Goldman-Rakic 1997) until recorded. OB slices were recorded in a continuously perfused (1 mL/min; Ismatec, Wertheim, Germany), submerged-slice recording chamber (RC-26; Warner Instruments, Hamden, CT, USA) with ACSF at 20-22°C. Slices were visualized at 109 and 409 using an Axioskop 2FS Plus microscope (Carl Zeiss Microimaging, Inc.) equipped with infrared detection capabilities (Dage MT1, CCD100; Michigan City, IN, USA). Electrodes were fabricated from borosilicate glass (#1405002; Hilgenberg, Mansfield, Germany) to a pipette resistance range from 4 to 7 MΩ. Following the determination of spike threshold, cells were stimulated with a long, peri-threshold current step (typically ranging from 5 to 50 pA) for 5000 ms every 10 s to acquire spike frequency data under ASCF conditions (Control). After the acquisition of a minimum of 10 min of recording, the bath was switched to QDs in ASCF (QD) and spike firing frequency was acquired using the same current injection for 10 min. Finally, the bath was switched a third time to apply MgTx-conjugated QDs (QD-MgTx) to the slice and the spike firing frequency was again acquired for a minimum of 10 min. Final working concentration of QD-MgTx added to the bath for these slice experiments was calculated to be 10 nM using a conjugate valence of 15.
Immunocytochemistry and QD binding HEK293 cells were grown on glass coverslips (#12-545-90; Fisher Scientific) and were transfected with GFP-Kv1.3 cDNA at confluency. Forty-eight hours post-transfection, cells were washed 19 with PBS and 19 with HEK293 bath solution to ensure that channels were in an open state such that QD-MgTx could bind the open pore of the channel. Cells were then incubated with the QD-MgTx conjugate (100 nM with respect to the QD) for 45 min, washed 29 with PBS, and then were fixed with 3% formaldehyde (#BP531-25; Fisher Scientific). The coverslips were mounted for imaging using a mounting agent containing 4 0 ,6-diamidino-2-phenylindole. Slides were viewed on an inverted Nikon Eclipse Ti Microscope outfitted with a Xe lamp and a color coolSNAP HQ2 CCD Camera (Nikon, Melville, NY, USA). A set of filter cubes (Chroma Technology, Rockingham, VT, USA) were used to detect 4 0 ,6-diamidino-2-phenylindole (340-380 nm excitation/435-485 nm emission), QD (532-587 nm excitation/608-683 nm emission), and GFP (450-490 nm excitation/500-550 nm emission). 
Statistical analyses
Results
MgTx can be efficiently coupled to quantum dots The QDs were conjugated to MgTx peptide using a EDC/ NHS condensation reaction (Fig. 1a) . The conjugate with a valence of 15 was used in all immunocytochemistry and electrophysiology experiments. Following conjugation, QDMgTx retained known QD absorption and emission properties ( Fig. 1b and c) . The generated QD-MgTx product was bath incubated for 45 min with GFP-Kv1.3-or pcDNA 3 -transfected HEK293 cells to explore the degree of colocalization of the channel with the peptide-conjugated QD. As shown in Fig. 1d , QD-MgTx conjugate labeling was visualized (panel iv) in GFP-Kv1.3-transfected cells (panels i-vi). However, QD-MgTx conjugate labeling was absent (panel x) in pcDNA 3 -transfected cells (panels vii-xii). Moreover, when MgTx was not bound to the QD, GFPKv1.3-transfected cells also remained unlabeled (panels xiiixviii). The QD signal showed colocalization with the GFPlabeled Kv1.3 channels (panels v-vi) indicating the binding of QD-MgTx to the Kv1.3 channels. The inhomogeneous signal of GFP is attributed to the heterogeneous expression of GFP-labeled Kv1.3 channels in transfected HEK293 cells as opposed to a stable transfection condition.
QD-MgTx inhibits Kv1.3 current on a slower time course than that of MgTx alone The kinetics of margatoxin binding is well characterized and has been shown to have a slow K on of 10 min and an even slower rate of dissociation with a K off of 2 h (Garcia-Calvo et al. 1993; Knaus et al. 1995) . Owing to its slow binding properties, it was feasible to tip-fill the patch pipette with control ACSF and back-fill the pipette with MgTx or QDMgTx to achieve basal current properties for a paired statistical design (within patch). Because MgTx binds the external face of the vestibule and has a rate of dissociation that would exceed the course of a typical patch recording, no attempt to dialyze the pipette or wash out of binding was attempted. Using this approach, both MgTx and the QDMgTx conjugate were able to inhibit outward current flow in Kv1.3-transfected HEK293 cells within a 25 min period ( Fig. 2a-e ; two-way mixed-design ANOVA using time as a factor, F(3, 88) = 62.98, p ≤ 0.001, and using treatment as a factor, F(3, 88) = 7.019, p ≤ 0.001; Bonferroni's post hoc test significantly different across time for MgTx and QDMgTx, p ≤ 0.001). The mean percent inhibition by QDMgTx was less than that of MgTx alone (79 AE 3.3%, n = 16 for MgTx vs. 66 AE 2.5%, n = 36 for QD-MgTx, Arcsine Percentage Student's t-test, p < 0.05). For patches treated with MgTx alone, 50% of the outward current was inhibited within 10.9 AE 1.1 min (n = 16) following patch stabilization ( Fig. 2a and b) . The inhibition of current was slower in patches treated with QD-MgTx, whereby it took 15.4 AE 1.2 min (n = 36) to achieve the same level of channel block (Student's t-test, p ≤ 0.0255; Fig. 2c and d) .
Regardless of the inhibition kinetics, within the 25 min recording block, both MgTx and QD-MgTx significantly decreased peak current amplitude in Kv1.3-transfected cells ( Fig. 2e ; significantly different T 0 vs. T 25 , two-way ANOVA using time as a factor; F(3, 88) = 62.98, p ≤ 0.0001). The QDs alone did not elicit a loss of voltage-activated currents (Fig. 2e) or change the kinetics of inactivation or deactivation of the channel (Table 1) , which infers that the particle itself did not occlude the channel non-selectively or modify its biophysical properties. We also explored the heat stability of MgTx (Fig. 2f ) along with several venom-based and small molecule peptide inhibitors including Pap-1 and Shk-186 (Schmitz et al. 2005; Upadhyay et al. 2013; Koshy et al. 2014) . Pap-1 was no longer an effective Kv1.3 inhibitor following heat exposure (33°C for 12 h retained < 10% inhibition, n = 5), and was no longer studied. Shk-186 (10 nM) exhibited heat stability (33°C for 48 h retained > 90% current inhibition, n = 16). MgTx retained the ability to inhibit Kv1.3 current after heat exposure for up to 2 days ( Fig. 2f ; significantly different from control, Kruskal-Wallis non-parametric ANOVA, Kruskal-Wallis Statistic = 34.57, p ≤ 0.0001, n = 5-19).
QD-MgTx conjugate selectivity across Shaker family members
MgTx has been demonstrated to be a potent inhibitor for Kv1.3, but it can also block other Kv family members at higher concentrations (Knaus et al. 1995; Bartok et al. 2014) . Because a systematic study has not been reported using Kv channels expressed in HEK293 cells, we first quantified the ability of MgTx to inhibit voltage-activated currents from Kv1.1-Kv1.7 family members. The same single-step depolarizing voltage was applied as in Fig. 2 , using an identical recording strategy. Representative voltageactivated currents are shown for select time (T) points following patch stability (Fig. 3a) . At a concentration of 1 nM, MgTx had no significant inhibitory effect on voltageactivated currents for Kv1.1, 1.4, 1.5, 1.6, or 1.7 (Fig. 3b , Mann-Whitney U, non-parametric paired t-test, p ≥ 0.05, n = 7-19). However, both Kv1.2 and Kv1.3 were inhibited by MgTx at this concentration (Fig. 3b , Mann-Whitney U, non-parametric paired t-test, p = 0.0013 for Kv1.2, n = 6-7; p = 0.0001 for Kv1.3, n = 16-18). Conjugation of the peptide inhibitor to QDs (QD-MgTx) did not alter this pattern of selectivity across the Kv family members (Fig. 4) . 3 (panels i-vi and xiii-xviii) or pcDNA 3 vector (panels vii-xii) and incubated with QD-MgTx (panels i-xii) or QD (panels xiii-xviii). DIC, differential interference contrast; DAPI, 4 0 ,6-diamidino-2-phenylindole nuclear stain; GFP, green fluorescent protein excitation wavelength; QD/QDMgTx, QD excitation wavelength; Merge 1 = green, blue, and red channels merged; Merge 2 = green, blue, red, and DIC channels merged; Scale bar = 10 lm.
Whereas the mean percent inhibition observed for patches recorded from Kv1.3-transfected cells was less under peptide-conjugated conditions than for that of MgTx alone ( Fig. 2e and f Fig. 3b; Fig. 4b ). Peak current magnitude of Kv1.1, Kv1.4, Kv1.5, and Kv1.6 was not significantly decreased either with time (control pipette solution) or with back-fill of either MgTx or QD-MgTx ( Fig. 3c; Fig. 4c ; paired t-test, p ≥ 0.05, n = 6-8). Peak current magnitude of Kv1.2 and Kv1.3 was not significantly decreased with time (control HEK pipette solution), but were significantly decreased with back-fill of either MgTx or QDMgTx ( Fig. 3c ; paired t-test, Kv1.2, p = 0.0122, n = 7; Kv1.3, p = 0.0001, n = 16; and Fig. 4c ; paired t-test, Kv1.2, p = 0.0278, n = 7; Kv1.3, p = 0.0001, n = 36).
MgTx shifts the activation voltage and slope of voltage sensitivity without changing voltage at half-activation in Kv1.3-transfected HEK 293 cells Because MgTx interacts with the pore vestibule, it is conceivable that properties of voltage sensing along the S4 transmembrane domain might also be affected. Mutations in the hydrophobic pore-forming region (H5) unique to Kv channels have been found to shift half-activation or the voltage dependence of activation (Yool and Schwarz 1991; Becker et al. 1996; del Camino et al. 2000) . This suggests that select pore residues may interact with the voltage sensor, the permeating ion affects the channel's own gating, or S6 structural changes in the form of a bend can modify activation gating. To study whether binding of MgTx in the pore affected voltage properties, we examined the I-V relation following peptide interaction as well as conductance properties calculated from tail currents elicited from brief step depolarizations (Fig. 5a ). As shown in Fig. 5b , the I-V relation was stable over the 25 min recording interval when the pipette was tip-and back-filled with control solution (two-way mixed repeated measures ANOVA, F(1, 84) = 1.558, p = 0.1143). When the pipette was switched to contain a back-fill of MgTx, however, the activation voltage strongly shifted by as much as 30 mV, prominently affecting the I-V relation between the À60 and 0 mV window ( Fig. 5e ; twoway mixed repeated measures ANOVA, F(1, 70) = 3.974, p = 0.0001, Bonferroni's post hoc test, 0 mV, p = 0.05; À10 mV, p = 0.001; À20 to 30 mV, p = 0.0001; and À40 mV, p = 0.001) while decreasing the peak current amplitude above 10 mV ( Fig. 5c ; two-way mixed repeated measures ANOVA, F(1, 70) = 8.227, p = 0.0001, Bonferroni's post hoc test, 10 mV, p = 0.001; 20-40 mV, p = 0.0001). Interestingly, the voltage at half-activation appears to have a modest left shift over time of the recording under control conditions ( Fig. 5f ; Student's t-test, p ≤ 0.0042, n = 7), which is absent when MgTx is incorporated into the back-fill ( Fig. 5g ; Student's t-test, p = 0.4986, n = 7). While there is no significant change in the V 1/2 for the residual current following MgTx application, there is a significant flattening of the relation and a great loss of voltage dependence as indicated by the slope of the voltage dependence (MgTx: T 0 , j = 5.0 vs. T 25 , j = 19.58; Student's t-test, p ≤ 0.05; Fig. 5g ). The steepness of the voltage dependence over time by comparison under control solutions was unchanged (Control: T 0 , j = 5.4 vs. T 25 , j = 4.31; Student's t-test, p ≥ 0.05; Fig. 5f ). This series of experiments exploring the I-V relation and channel conductance was repeated, but substituting the QD-MgTx conjugate (Fig. 6) . Addition of Mean AE SEM inactivation and deactivation rate (s) for Kv1.3 currents elicited by a step depolarization from V h = À90 to V c = +40 during tip pipette perfusion of artificial cerebral spinal fluid (ACSF) or QDs over the recording period; T 0 (time 0)-T 25 (time 25). Neither ACSF nor QD perfusion elicited a change in the Τ inact or the Τ deact overtime (Paired t-test, p > 0.05, n = 5-6 patches). The Τ inact and the Τ deact properties were not significantly different (NS) at the end of the recording (T 25 ) when comparing ACSF versus QD perfusion (Student t-test, p > 0.05, n = 5-6 patches).
the QD dampened the shift in activation voltage observed with MgTx approximately 20 mV, where it affected the I-V relation in the À40 to À20 mV window ( Fig. 6e ; two-way mixed repeated measures ANOVA, F(1, 224) = 3.701, p = 0.0001, Bonferroni's post hoc test, 0 to À10 mV, p = 0.05; À20 mV, p = 0.0001; À30 mV, p = 0.01; and À40 mV, p = 0.05) while decreasing the peak current amplitude above À10 mV ( Fig. 6c ; two-way mixed repeated measures ANOVA, F(1, 224) = 24.09, p = 0.0001, Bonferroni's post hoc test, À10 mV, p = 0.05; 0-40 mV, p = 0.0001). Addition of the QD to control solutions similarly caused a left shift in V 1/2 previously observed as a time-dependent change in recording (Fig. 6f vs. Fig. 5f ; Student's t-test, p ≤ 0.007, n = 8). Likewise, substitution of the QD-MgTx conjugate for MgTx similarly flattened the Boltzmann relation of the conductance curve and lessened the steepness of the voltage dependence without modifying the V 1/2 (Fig. 6g vs. Fig. 5g ; QD-MgTx: T 0 , j = 5.0 vs. T 25 , j = 9.8; Student's t-test, p ≤ 0.05; V 1/2 not significantly different, Student's t-test, p = 0.3794, n = 17). QD-MgTx enhances mitral cell action potential firing frequency in olfactory bulb slices The olfactory bulb (OB) expresses a cadre of Kv family members including 1.2, 1.3, and 1.4 (Kues and Wunder 1992; Wang et al. 1994; Fadool and Levitan 1998; Fadool et al. 2004) . Within the neural lamina of the OB, the major output neuron to relay olfactory coding information to higher cortical regions is the mitral cell (MC). Based on pharmacological sensitivity to MgTx and Shk-186 as well as electrophysiological characterization using Kv1.3 À/À mice, it is estimated that 60-80% of the outward current in MCs is carried by the Kv1.3 channel (Fadool and Levitan 1998; Colley et al. 2004; Fadool et al. 2004 Fadool et al. , 2011 . Targeting
MCs within the OB neurolamina as an in situ target for QDMgTx, we anticipated an increase in action potential (AP) firing frequency in response to bath application of the peptide conjugate (Fig. 7a) . Indeed, QD-MgTx significantly increased the AP firing frequency over that of control ACSF, and QDs alone did not change the AP firing compared to that of control ACSF ( Fig. 7c; (Mast and Fadool 2012; Thiebaud et al. 2016) and with other neuromodulators that act to decrease Kv1.3 activity (Fadool et al. 2011) .
Discussion
Our study demonstrates that it is possible to chemically conjugate a pore-blocking, venom-derived peptide to a nanoparticle and still inhibit the targeted channel without altering other biophysical properties. We have shown that QD-MgTx conjugates significantly decrease Kv1.3 current in HEK293-transfected cells and increase spike firing frequency of MCs that express native Kv1.3. Using immunocytochemical approaches, we found that the QD-MgTx conjugates bind to HEK293-transfected cells, but fail to bind in the absence of Kv1.3 cDNA. Because Kv1.3 channels retain the same biophysical properties when the vestibule is blocked with either MgTx or QD-MgTx, and the peptide itself is thermally stable for up to 48 h, we judge that the QD conjugate will be an effective tool to target and then track MgTx to Kv1.3 channels in discrete brain regions and with potential therapeutics for diseases with a well-researched role for the channel's involvement, such as multiple sclerosis, asthma, autoimmune dysfunctions, or disruption in energy homeostasis.
We have been successful in conjugating MgTx to fluorescent QDs without affecting the known biophysical properties of Kv1.3 when bound to a pore-blocking peptide. Using EDC carbodiimide chemistry, we activated carboxyl groups found on the QDs such that they would form an amide bond with basic residues found on the surface of MgTx. MgTx contains a b-sheet and an a-helix, and is stabilized by three disulfide bonds formed between Cys7-Cys29, Cys13-Cys34, and Cys17-Cys36 (Bednarek et al. 1994; Johnson et al. 1994; Chen and Chung 2014) . The basic residues on MgTx's external surface form favorable electrostatic interactions, typically H-bonds or salt bridges, with acidic residues of the outer pore vestibule of Kv1.3. These interactions provide the peptide with a strong affinity for the channel, with an average distance between interacting residues of 1.7-3.3 A (Chen and Chung 2014) , and it has previously been calculated that fewer electrostatic interactions correlate with lower binding affinity (Chen et al. 2011) . Lys28 is the most important of these residues involved with blocking Kv1.3. Lys28 is located within the second strand of the b-sheet and it disrupts the negatively charged selectivity filter of the channel upon binding the pore. When Lys28 is mutated to Ala, MgTx's ability to inhibit Kv1.3 is abolished (Anangi et al. 2012 ). Although we had no direct control over which basic residues were targeted during the conjugation to QDs, our electrophysiological data demonstrated that chemical conjugation through this methodology did not prevent MgTx from inhibiting Kv1.3, thus it is highly likely that our conjugation did not significantly affect the surface residues required to form favorable electrostatic interactions with the channel.
Albeit the QD-MgTx conjugate inhibited Kv1.3, it is interesting that the kinetics of Kv1.3 current block were slower with QD-MgTx than with that of MgTx alone. It is not certain if the time to half-inhibition was up to 3-4 min slower because the QD-conjugated peptide took longer to perfuse in the patch electrode or if the dynamics of pore interaction had been slightly changed. Given the fact that the percent inhibition by QD-MgTx was also slightly less than that of MgTx alone (66 vs. 79% inhibition) and the fact that another Kv channel's inhibition was not altered with the addition of the QD (Kv1.2) argues that the changed kinetics and efficacy of the block are more likely attributed to a minor change in the interaction of the QD-MgTx conjugated with the vestibule of Kv1.3 and not associated with pipette perfusion changes or drag of the QD. Another potential consideration is that the amines targeted for chemical conjugation likely play a role in the peptide's affinity for Kv1.3. Thus, if fewer basic residues are exposed on the surface of MgTx, its affinity for Kv1.3 might be reduced. Another possibility concerns peptide orientation. Although a significant number of MgTx peptides must have been bound in a formation that retained their activity, it is quite possible that some of the estimated 15 bound MgTx peptides were bound in an unfavorable orientation that reduced or prevented activity. In light of this, our estimated concentration of MgTx could be less, and in turn could account for the reduced ability in inhibiting Kv1.3 or a slower time course.
Although unbound QDs have no effect on Kv1.3 current, it is possible that when MgTx is bound to QDs, it is not able to sit within the pore in a natural orientation as a result of steric constraints. In a molecular dynamics study in which His399 within the pore of hKv1.3 was mutated to Asp, the distance between interacting residues of MgTx and Kv1.3 was altered owing to changed electrostatic interactions, which reduced the strength of block (Nikouee et al. 2012) . The Kv1.3 pore and its four voltage sensors are predicted to be 3 nm in length across the membrane (Long et al. 2005a,b) , while the QDs used for these experiments are 12 nm in diameter with capping ligands. It is conceivable that the larger size of the QDs might reduce the average distance between interacting residues of MgTx and Kv1.3, potentially attributed to steric hindrance, altering the orientation in which the peptide sits within the pore, and reducing its strength of block.
While MgTx is widely considered a selective Kv1.3 inhibitor (K d = 11.7 pM) (Garcia-Calvo et al. 1993) , it has been reported to inhibit hKv1.1 and hKv1.2 at higher concentrations. At a 1 nM concentration, we did observe inhibition of rKv1.2, but not rKv1.1. This was not surprising given that the K d for Kv1.1 is 4 nM, whereas that for Kv1.2 is 6.4 pM (Bartok et al. 2014) . Because the goal of this work was to design a methodology for binding MgTx to a QD and to test the efficacy of the conjugate, we did not explore other concentrations of the peptide. Following binding of MgTx to the QD, the conjugate retained the observed selectively profile for MgTx, inhibiting both Kv1.3 and Kv1.2, but not Kv1.1. To better understand how the QD-MgTx conjugate inhibits Kv1.3, we explored the I-V relation and conductance properties of Kv1.3 before and after block by MgTx or the QD-MgTx conjugate. When unbound MgTx inhibits Kv1.3, a strong shift in activation voltage and a clear loss of voltage dependence is observed in comparison to control solution. Similar voltage changes are observed when the QD-MgTx inhibits the channel compared to QD control, but not as strong. This is not surprising as the QD-MgTx conjugate also has a reduced ability to inhibit Kv1.3, however, this similar shift in the I-V relation further confirms the presence of MgTx on the conjugate and that the QDs alone have no effect on channel activity.
When QD-MgTx was applied to ex vivo OB slices, not only did it enhance AP firing frequency as anticipated but it also did so by increasing the AP burst length and decreasing the pause duration or inter-burst interval, and did not affect the inter-spike interval or ISI. This pattern of enhanced excitability of MCs is the same as that recorded following application of MgTx alone, the same as that attributed to neuromodulators that specifically reduce Kv1.3 current, and is observed in mice with Kv1.3-targeted deletion (Fadool et al. , 2011 Tucker et al. 2013; Thiebaud et al. 2016) . Even though the ability for channel inhibition by QD-MgTx versus MgTx alone demonstrates a modest difference in efficacy and kinetics (Fig. 2) , this does not appear to affect the ability for enhanced AP firing in native Kv1.3-expressing neurons. It may also suggest that the degree of Kv1.3 inhibition by QD-MgTx is sufficient for depolarizing the neuron to elicit an increased AP firing frequency (69) that is on par with that observed for MgTx alone (Thiebaud et al. 2016) . Venom-derived ion channel inhibitors selectively inhibit their target of interest and, in our case, are able to target native Kv1.3 channels in a brain slice. Molecules like our developed QD-MgTx conjugate will be advantageous in future drug delivery studies as they will provide a means of tracking the drug molecule following delivery. The developed QD-MgTx conjugate has a similar ability of inhibiting Kv1.3 and exciting MCs of the OB. Future therapeutic interventions using intranasal delivery of QD-MgTx could be developed to enhance olfactory ability, increase metabolism, or modulate olfactory-coded information to this CNS neural network.
